View More
In this downloadable slideset, CCO’s expert faculty reviews current clinical use of PARP inhibitors in the treatment of patients with newly diagnosed ovarian cancer.
Antonio Gonzalez-Martin, MD, PhD
Released: December 17, 2020
In this downloadable slideset, CCO’s expert faculty reviews PARP inhibitors in the treatment of patients with recurrent ovarian cancer.
Ursula Matulonis, MD
Released: December 22, 2020
In this downloadable slideset, CCO’s expert faculty reviews different PARP inhibitors in the treatment of patients with newly diagnosed ovarian cancer.
Prof Ignace Vergote
Released: December 22, 2020
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.